- Presentations
- 5
- Markets
- 1
Bosulif is a brand of Bosutinib marketed by Pfizer Laboratories, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Bosutinib
- Brand owner
- Pfizer Laboratories
- Registered in
- United States
- Strengths and forms
- 100 mg capsule, 50 mg capsule, 100 mg tablet, 400 mg tablet, 500 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Bosulif 100 mg capsuleOral | Pfizer Laboratories | US FDA | Available on request |
| Bosulif 50 mg capsuleOral | Pfizer Laboratories | US FDA | Available on request |
| Bosulif 100 mg tabletOral | Pfizer Laboratories | US FDA | Available on request |
| Bosulif 400 mg tabletOral | Pfizer Laboratories | US FDA | Available on request |
| Bosulif 500 mg tabletOral | Pfizer Laboratories | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Bosulif
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.